178 related articles for article (PubMed ID: 21944470)
1. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle.
Kim JK; Choi KJ; Lee M; Jo MH; Kim S
Biomaterials; 2012 Jan; 33(1):207-17. PubMed ID: 21944470
[TBL] [Abstract][Full Text] [Related]
2. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.
Hwang DW; Ko HY; Lee JH; Kang H; Ryu SH; Song IC; Lee DS; Kim S
J Nucl Med; 2010 Jan; 51(1):98-105. PubMed ID: 20008986
[TBL] [Abstract][Full Text] [Related]
3. A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins.
Ko HY; Choi KJ; Lee CH; Kim S
Biomaterials; 2011 Feb; 32(4):1130-8. PubMed ID: 21071077
[TBL] [Abstract][Full Text] [Related]
4. Molecular beacon-based bioimaging of multiple microRNAs during myogenesis.
Kang WJ; Cho YL; Chae JR; Lee JD; Choi KJ; Kim S
Biomaterials; 2011 Mar; 32(7):1915-22. PubMed ID: 21122913
[TBL] [Abstract][Full Text] [Related]
5. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
[TBL] [Abstract][Full Text] [Related]
6. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of fluorescent dye-doped silica nanoparticles for target-cell-specific delivery and intracellular microRNA imaging.
Li H; Mu Y; Qian S; Lu J; Wan Y; Fu G; Liu S
Analyst; 2015 Jan; 140(2):567-73. PubMed ID: 25417796
[TBL] [Abstract][Full Text] [Related]
8. Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon.
Lee J; Choi KJ; Moon SU; Kim S
Biomaterials; 2016 Jan; 74():109-18. PubMed ID: 26454049
[TBL] [Abstract][Full Text] [Related]
9. A reverse complementary multimodal imaging system to visualize microRNA9-involved neurogenesis using peptide targeting transferrin receptor-conjugated magnetic fluorescence nanoparticles.
Jo MH; Ali BA; Al-Khedhairy AA; Lee CH; Kim B; Haam S; Huh YM; Ko HY; Kim S
Biomaterials; 2012 Sep; 33(27):6456-67. PubMed ID: 22727464
[TBL] [Abstract][Full Text] [Related]
10. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
11. Dual optical biosensors for imaging microRNA-1 during myogenesis.
Kang WJ; Cho YL; Chae JR; Lee JD; Ali BA; Al-Khedhairy AA; Lee CH; Kim S
Biomaterials; 2012 Sep; 33(27):6430-7. PubMed ID: 22698721
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
[TBL] [Abstract][Full Text] [Related]
13. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.
Li L; Hou J; Liu X; Guo Y; Wu Y; Zhang L; Yang Z
Biomaterials; 2014 Apr; 35(12):3840-50. PubMed ID: 24486214
[TBL] [Abstract][Full Text] [Related]
14. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
15. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
Wu J; Song C; Jiang C; Shen X; Qiao Q; Hu Y
Mol Pharm; 2013 Oct; 10(10):3555-63. PubMed ID: 23679916
[TBL] [Abstract][Full Text] [Related]
16. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Nanomedicine (Lond); 2018 Nov; 13(21):2729-2758. PubMed ID: 30394201
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
Chen S; Wang H; Ng WL; Curran WJ; Wang Y
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
[TBL] [Abstract][Full Text] [Related]
18. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
Lu RM; Chang YL; Chen MS; Wu HC
Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768
[TBL] [Abstract][Full Text] [Related]
19. Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer.
Zhu HZ; An JH; Yao Q; Han J; Li XT; Jiang FL; Chen GP; Peng LN; Li YS; Sun JG; Chen ZT
Molecules; 2014 Sep; 19(9):14710-22. PubMed ID: 25230125
[TBL] [Abstract][Full Text] [Related]
20. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
